The agreement will strengthen AstraZeneca’s aclidinium respiratory franchise and is expected to add immediate revenues with long-term growth potential. Upon completion of the transaction, AstraZeneca will own the
Valued at $90 per Hospira share, the acquisition is expected to improve Pfizer’s Global Established Pharmaceutical (GEP) Business as well as strengthen its portfolio of generic injectable drugs
As part of the deal, the two parties will focus on preclinical research involving QR Pharma’s lead drug candidate Posiphen. The deal will see investigators at Rockefeller conduct
Around 200 patients with first-line metastatic Stage IV non-squamous NSCLC whose tumors do not have an epidermal growth factor receptor (EGFR) or anaplastic lymphoma kinase (ALK) mutation will
The IND acceptance allows the company to start a Phase I/II clinical trial of the ZFP Therapeutic in transfusion-dependent patients with beta-thalassemia major. Scheduled to begin in 2015,
Teflaro is designed to treat acute ABSSSI caused by susceptible bacterial isolates of the following gram-positive and gram-negative microorganisms: Staphylococcus aureus, Streptococcus pyogenes, Streptococcus agalactiae, Escherichia coli, Klebsiella
An independent data monitoring committee determined that the open-label, multicenter, randomized two-arm trial met its primary endpoint early. Roche chief medical officer and head of Global Product Development
The submission is part of the company’s ATX-101 global development program and follows regulatory applications in the US, Canada and Switzerland. In Australia, the regulatory application was supported
For the sNDA, the anticipated Prescription Drug User Fee Act (PDUFA) action date will be in October 2015. The submission of sNDA was based on data from a
The drug is indicated to treat patients with STS, including liposarcoma and leiomyosarcoma subtypes, who have received prior chemotherapy including an anthracycline. STS are a type of cancer
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.